Clinical trial / 2017
Six months of alternate day fasting induced weight loss without adversely altering markers of bone metabolism or bone mineral density in overweight and obese adults.
A 6-month randomized controlled trial evaluated 100 overweight and obese subjects assigned to alternate day fasting (ADF), daily calorie restriction (CR), or a control group. By month 6, body weight decreased similarly in ADF (-7.8±1.2%) and CR (-8.8±1.5%) compared to controls (P < 0.001). Lean mass, total body bone mineral content, total body bone mineral density, osteocalcin, bone alkaline phosphatase, and CTX remained unchanged across all groups. IGF-1 increased in the CR group (P < 0.01) but showed no change in the ADF or control groups, and subgroup analyses by menopausal status revealed no differences.
- Study type
- 6-month randomized controlled trial
- Who was studied
- 100 overweight and obese subjects
- What was measured
- Body weight, bone mineral content, bone mineral density, lean mass, and circulating markers of bone metabolism
THE PAPER
Effect of alternate day fasting on markers of bone metabolism: An exploratory analysis of a 6-month randomized controlled trial.
Barnosky A, Kroeger CM, Trepanowski JF, Klempel MC, Bhutani S, Hoddy KK, Gabel K, Shapses SA, Varady KA. Nutr Healthy Aging, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.